Real Health Diagnostics Inc., a provider of the at-home GI-MAP (Gastrointestinal Microbial Assay Plus) stool test, is highlighting an important diagnostic gap during the 2026 multi-state Cyclospora outbreak. Standard stool tests may fail to detect Cyclospora cayetanensis, while the GI-MAP test, which is available through Real Health Diagnostics Inc., identifies it using quantitative PCR (qPCR) alongside more than 85 additional gut health markers from a single at-home stool sample.
GI-MAP Test: What It Detects and How
The GI-MAP test, available through gimaptest.com across the United States and Canada, uses qPCR DNA technology to screen for Cyclospora cayetanensis and 30+ additional parasites, bacterial and viral pathogens, H. pylori, fungi, and intestinal health markers — all from a single at-home stool sample collected by the patient and reviewed by a qualified practitioner. Unlike conventional ova-and-parasite (O&P) microscopy, which the CDC, Mayo Clinic Laboratories, and ARUP Laboratories confirm frequently misses Cyclospora, the GI-MAP test’s molecular approach detects the parasite’s DNA directly, providing results that standard panels cannot reliably produce.
The GI-MAP test is a practitioner-ordered laboratory test. It screens for and identifies pathogens; it does not diagnose, treat, cure, or prevent disease. Results are reviewed and interpreted by a qualified healthcare practitioner.
Why the 2026 Cyclospora Outbreak Highlights the Need for Molecular Testing
According to the CDC and FDA, as of July 20, 2026, 1,644 confirmed cases of Cyclospora infection have been linked to shredded iceberg lettuce served at Taco Bell locations in Indiana, Kentucky, Michigan, Ohio, and West Virginia, traced to Taylor Farms de Mexico, which initiated a voluntary recall on July 17, 2026. The CDC notes the true number of illnesses is likely significantly higher, in part because Cyclospora requires specific laboratory testing not included in standard stool panels — and many patients who seek care never receive the right test.
This is the diagnostic gap that GI-MAP test addresses. Patients who ate recalled lettuce, developed watery and relapsing diarrhea with an incubation period of approximately one week, and then received a standard O&P stool test may have been told their results were negative. That result does not rule out Cyclospora. It reflects the limitations of conventional microscopy, which requires special acid-fast staining or UV fluorescence to detect the parasite — techniques not routinely applied in standard panels. The GI-MAP test’s qPCR approach does not rely on those techniques, detecting Cyclospora at the DNA level.
“The hardest part of this outbreak for patients isn’t just getting sick — it’s that a standard stool test can come back negative even when Cyclospora is the cause. It’s a parasite that routine testing often misses, so people go undiagnosed and untreated. Comprehensive molecular testing changes that, and just as importantly, it helps people understand what their gut needs to recover afterward. If you’re severely ill, though, see your doctor first — this is about getting answers, not replacing care.”— Madison Ordway, FDN-P, Real Health Diagnostics Inc.
Post-Infection Recovery: What GI-MAP Test Reveals Beyond the Acute Infection
A comprehensive stool test like the GI-MAP provides practitioners with more than a positive or negative result for a single pathogen. Its 85+ markers include intestinal health indicators — inflammatory markers, gut microbiota balance, and digestive function parameters — that help practitioners assess the state of the gut environment after an infection. Cyclospora infection is known for relapsing symptoms and post-infection dysbiosis; addressing recovery systematically requires understanding the full picture of gut health, not just whether the parasite is still present. Real Health Diagnostics’ gut recovery guidance covers this phase in detail for patients and practitioners.
About Real Health Diagnostics Inc. and GI-MAP
Real Health Diagnostics Inc. operates gimaptest.com, offering the at-home GI-MAP stool test across the United States and Canada. The GI-MAP uses quantitative PCR (qPCR) DNA technology to screen 85+ markers from a single at-home sample, reviewed by a qualified practitioner. It is one of the most comprehensive at-home gut health tests available in the North American market, covering parasites including Cyclospora cayetanensis, bacterial and viral pathogens, H. pylori, fungi, and intestinal health markers.
GI-MAP is a trademark of Diagnostic Solutions Laboratory, LLC. Real Health Diagnostics Inc. works with authorized providers and is not affiliated with or endorsed by Diagnostic Solutions Laboratory. This content is educational and is not medical advice or a diagnosis. Anyone experiencing severe or acute symptoms should see a healthcare provider immediately.
